Casitas B cell lymphoma (Cbl) proteins are negative regulators for T cell antigen receptor (TCR) signaling. Their role in thymocyte development remains unclear. Here we show that simultaneous inactivation of c-Cbl and Cbl-b in thymocytes enhanced thymic negative selection and altered the ratio of CD4 + and CD8 + T cells. Strikingly, the mutant thymocytes developed into CD4 + -and CD8 + -lineage T cells independent of the major histocompatibility complex (MHC), indicating that the CD4 + -and CD8 + -lineage development programs are constitutively active in the absence of c-Cbl and Cbl-b. The mutant double-positive (DP) thymocytes exhibited spontaneous hyperactivation of nuclear factor-kappa B (NF-kB). Additionally, they failed to downregulate the pre-TCR and pre-TCR signaling. Thus, our data indicate that Cbl proteins play a critical role in establishing the MHC-dependent CD4 + and CD8 + T cell development programs. They likely do so by suppressing MHC-independent NF-kB activation, possibly through downmodulating pre-TCR signaling in DP thymocytes.
Introduction
T lymphopoiesis is a sequential developmental process regulated by thymic environmental signals (Fowlkes and Pardoll, 1989; Love and Chan, 2003; von Boehmer, 1988) . The first step of T cell development involves successive rearrangements of the V-(D)-J genes in CD4 and CD8 double-negative (DN) T precursors, and only those cells with a successfully rearranged TCRb gene may develop further into CD4 and CD8 DP stage of thymocytes. This step in T cell development is controlled by signaling of growth factor receptors such as interleukine-7 receptor (IL-7R) and pre-TCR and occurs independently from the MHC because pre-TCR signaling is constitutively active in the absence of the MHC (Hayday et al., 1999; von Boehmer and Fehling, 1997) . At the DP stage, thymocytes may decide to become either CD4 + helper-T (Th) or CD8
+ cytotoxic-T (Tc) cells and are positively and negatively selected based on the interaction between the TCR and the MHC expressed by thymic accessory cells (Kaye et al., 1989; Sha et al., 1988; Teh et al., 1988) . While thymocytes expressing a TCR that recognize MHC-I choose CD8 + T cell fate and develop into Tc cells, cells that express a TCR recognizing MHC-II commit to CD4 + lineage and become Th cells (Cosgrove et al., 1991; Grusby et al., 1991; Zijlstra et al., 1990) .
Development of CD4 + and CD8 + T cells is regulated by signals delivered by the TCR; however, it remains unclear how the incoming TCR signals are connected to the CD4 + and CD8 + lineage-development program. Current opinion indicates that engagement of the TCR with MHC initiates a TCR-downstream signaling cascade, starting with tyrosine phosphorylation of the immunoreceptor tyrosine-based activation motifs (ITAMs) of the CD3 complex by the Src-family tyrosine kinase Lck (lymphocyte-specific protein tyrosine kinase) (Weiss and Littman, 1994) . The phosphorylated ITAMs then recruit tyrosine kinase Zap70 (zeta-chain associated protein 70 kDa) to the engaged TCR complexes, leading to Zap70 activation. Upon activation, Zap70 phosphorylates membrane protein LAT (linker for activation of T cells), which then assembles a complex of multisignaling molecules, including Grb2 (growth-factor receptor binding protein 2), Gads (Grb2-related adaptor protein), SLP-76 (the SH2-domain-containing leukocyte phosphoprotein of 76 kDa), Vav, PLCg-1 (phospholipase Cgamma-1), and Itk (interleukine-2 tyrosine kinase) (Koretzky and Myung, 2001; Lucas et al., 2003) . Coordination between these signaling components leads to multiple downstream cellular responses, including Ca 2+ mobilization, cytoskeleton reorganization, and activation of various nuclear factors that eventually determine the various T cell development programs.
The Cbl family of proteins are signaling adaptors that associate with many different receptors and intracellular signaling components (Rao et al., 2002; Thien et al., 2001) . c-Cbl and Cbl-b, two highly homologous members of the Cbl family, are coexpressed in hematopoietic-lineage cells and function as E3-ubiquitin ligases (Joazeiro et al., 1999) . Biochemical analyses reveal that Cbl proteins promote the ubiquitination of several Cbl-associated proteins, thereby regulating the degradation or intracellular association of these molecules (Liu, 2004) . In the immune system, protein ubiquitination has been implicated in the regulation of T-lymphocyte differentiation into Th2 cells, as well as in the induction of immune tolerance (Fang et al., 2002; Naramura et al., 2002) . However, it remains unclear whether Cbl proteins also control the development of early T cells. c-Cbl and Cbl-b are differentially expressed in thymocytes and mature T cells (Naramura et al., 2002) . Such developmentally regulated pattern of expression is consistent with their predominant role either in thymocyte development or in peripheral T cell activation (Bachmaier et al., 2000; Chiang et al., 2000; Naramura et al., 1998 Naramura et al., , 2002 . At the molecular level, c-Cbl and Cbl-b share a high sequence homology and are coexpressed in developing thymocytes (Naramura et al., 2002) , thus suggesting that they may have a redundant function in early T cell development and differentiation. In this report, we show that simultaneous ablation of c-Cbl and Cbl-b in thymocytes resulted in spontaneous development of CD4 + and CD8 + T cells in the absence of the MHC. The mutant DP thymocytes failed to downmodulate pre-TCR and exhibited constitutive pre-TCR signaling. These results together indicate that Cbl proteins are the key players in switching pre-TCR signaling to TCR signaling, a process critical for establishing the MHCrestricted repertoire of CD4 + and CD8 + T cells.
Results

Generation of c-Cbl and Cbl-b Double-Deficient Mice
Homozygous germline c-Cbl and Cbl-b double-deficient mice died before day 10.5 of embryogenesis (E10.5) (Naramura et al., 2002) . To study the function of Cbl proteins in T cell development, we generated T cell-specific c-Cbl and Cbl-b double-deficient mice with the Cre-loxP system (Naramura et al., 2002 ) (see also Figure S1A in the Supplemental Data available online). These mice were homozygous for the Cbl-b null (Cblb
2/2
) and c-Cbl floxed (Cbl f/f ) mutations and carried an Lck-cre transgene that specifically expressed the Cre recombinase in thymocytes (Takahama et al., 1998) . Our results indicated that the Lck-Cre transgenic mice mediated deletion of floxed gene in as early as DN3 stage of thymocytes ( Figure S1B ). We confirmed the absence of c-Cbl and Cbl-b proteins in the purified DP thymocytes of the resulting c-Cbl and Cbl-b double-deficient mice by immunoblot hybridization ( Figure S1C ). Hereafter, we refer to these T cell-specific c-Cbl and Cbl-b double-
The Cbl Double Deficiency Enhances Thymic Negative Selection It has been shown previously that both c-Cbl-deficient (Cbl
) and Cbl-b-deficient (Cblb 2/2 ) mice have normal numbers of thymocytes (Bachmaier et al., 2000; Chiang et al., 2000; Naramura et al., 1998) . In contrast, we found that Cbl 2/2 , Cblb 2/2 mice had significantly lower numbers of thymocytes than did wild-type controls (Figure 1A) . Analysis of DN thymocytes revealed that the total numbers of DN1-4 subsets were mostly comparable between Cbl 2/2 , Cblb 2/2 and wild-type mice, except a slight increase in DN3 thymocytes in the mutant mice (p < 0.001) ( Figures 1A and 1B) . However, the number of DP thymocytes in Cbl 2/2 , Cblb 2/2 mice was reduced to about 30%-40% of that in wild-type controls (p < 0.001) ( Figure 1A ). The impaired DP T cell development could not be explained by the deficiency in TCRb gene rearrangement, as shown by the fact that we detected comparable levels of dsDNA breaks at TCRb recombination signal sequences (RSSs) in purified mutant DN2-4 cells ( Figure S2A ), nor could it be explained by lack of DN3-DN4 expansion (b-selection), as shown by the fact that the mutant DN3 and DN4 cells proliferated as efficiently as did the wild-type cells ( Figure S2B ). These results thus suggest that the reduction of thymocyte numbers happens after the DN stage.
The total number of DP thymocytes could be affected by thymic positive and negative selection, so we next determined whether thymic selection was altered in the absence of c-Cbl and Cbl-b. To this end, we crossed Cbl Figure 1C ); however, in female H-Y TCR transgenic mice, the ablation of Cbl proteins appeared to convert thymic positive selection of H-Y TCRexpressing CD8 + T cells into negative selection; DP and CD8 + thymocytes were markedly diminished in thymi of Cbl 2/2 , Cblb 2/2 mice ( Figure 1D ). Conversion of positive selection into negative selection was also observed in the CD4 + T cell compartment: both DP and CD4 + thymocytes were deleted in Cbl 2/2 , Cblb 2/2 but not in wild-type 5C.C7 TCR transgenic mice ( Figure 1D ). Based on these results, we conclude that the Cbl double deficiency enhances thymic negative selection, leading to deletion of T cells that are usually positively selected in wild-type mice. Moreover, we propose that the enhanced negative selection is at least one of the reasons responsible for the reduced number of DP thymocytes in the mutant mice. requires TCR-MHC-I interaction. As shown in Figure 3A , we found that CD8 + T cells were still generated from Cbl , Cblb 2/2 mice to MHC-I and II doubledeficient mice and analyzed T cell development in the resulting c-Cbl, Cbl-b, MHC-I, and MHC-II (MHC-Cbl) quadruple-deficient mice ( Figure 3C ). We found that the total numbers of thymocytes in Cbl-MHC quadruple-deficient mice were comparable to that in Cbl 2/2 , Cblb 2/2 mice. Strikingly, while few CD4 + and CD8 + thymocytes were generated in MHC-I and II doubledeficient mice, both CD4 + and CD8 + T cells were as efficiently generated in Cbl-MHC quadruple-deficient mice as that in Cbl 2/2 , Cblb 2/2 mice. Additionally, a biased ratio of CD8 + versus CD4 + T cells was also observed in Cbl-MHC quadruple-deficient mice ( Figure 3C ). These Cbl-MHC quadruple-deficient CD4 + and CD8 + T cells resembled positively selected Cbl 2/2 , Cblb 2/2 CD4 + and CD8 + thymocytes, as shown by the fact that the majority of them downmodulated HSA and expressed the TCR at the amounts comparable to that expressed by Cbl 2/2 , Cblb 2/2 CD4 + and CD8 + T cells ( Figure 3D ). Additionally, the quadruple-deficient CD4 + and CD8 + T cells appeared to be functionally normal T cells rather than immature CD4 + and CD8 + single-positive T cells: they proliferated vigorously and secreted a high amount of IL-2 upon TCR stimulation ( Figure 3E , Cblb 2/2 DP thymocytes in the presence or absence of anti-CD3 stimulation. To eliminate background signaling elicited by intrathymic stimuli in vivo, we cultured thymocytes at 37 C for 10-12 hr in vitro before biochemical analysis. This treatment has been shown to eliminate the basal TCR signaling activated by the MHC molecules that are expressed on thymic accessory cells (Nakayama et al., 1991) . In the absence of anti-CD3 stimulation, we could not find substantial amounts of spontaneous tyrosine phosphorylation of the total cellular proteins or individual signaling components such as LAT, Zap70, Vav, PLCg-1, and Erk1 and 2 ( Figures 4A and 4B) , suggesting that the TCR-proximal signaling events examined above are not spontaneously activated in Cbl 2/2 , Cblb 2/2 thymocytes in the absence of TCR stimulation. After anti-CD3 stimulation, the magnitude of tyrosine phosphorylation of total cellular proteins was not measurably , and CD8 + thymocytes. Thymocytes from wild-type, MHC-I and II doubledeficient, Cbl double-deficient, and Cbl-MHC quadruple-deficient mice were stained with anti-CD4 and CD8 in combination with either anti-HSA or anti-TCRb chain. Shown are histograms of HSA and TCRb expression on the gated DP (shadow), CD4 + (solid line), CD8 + (dashed line) thymocytes. Results are representatives of three independent experiments. (E) Proliferation and IL-2 production of Cbl-MHC quadruple-deficient thymocytes. Total thymocytes were either unstimulated or stimulated with plate-bound anti-CD3 and soluble anti-CD28 for 3 days for CFSE-labeling experiment, or for 18 hr followed by 6 hr of incubation with brefeldin A for IL-2 production assay. enhanced, and in some cases, for example p90 and p36-p38, was even weakened in Cbl 2/2 , Cblb 2/2 thymocytes as compared to that in wild-type cells ( Figures 4A and  4B ). The strong phosphorylated 120 kDa protein band in wild-type cells, which was absent in Cbl , Cblb 2/2 DP thymocytes ( Figure 4C ). These results collectively indicate that the TCR-proximal signaling pathways studied above are neither spontaneously activated nor generally hyperactive in Cbl NF-kB is a transcription factor that can be activated by the TCR (Kane et al., 2002) . Enforced activation of NF-kB may substitute pre-TCR and TCR signals to support the development and survival of DP and CD4 + and CD8 + thymocytes (Voll et al., 2000) . We found that, in contrast to wild-type thymocytes in which NF-kB binding activity was moderately enhanced only after TCR stimulation, Cbl
, Cblb 2/2 thymocytes exhibited a markedly higher level of NF-kB binding activities even in the absence of TCR stimulation ( Figure 5 ). The constitutive activation appeared to be selective for NF-kB because the activity of AP-1, another transcription factor whose activation depends on TCR-induced MAP kinases, was not spontaneously active in Cbl 2/2 , Cblb 2/2 cells ( Figure 5 ). Based on these results, we conclude that the signaling cascade upstream of the NF-kB pathway is constitutively active in Cbl 2/2 , Cblb 2/2 thymocytes. Since NF-kB activation may substitute TCR signaling in promoting T cell development (Voll et al., 2000), our data also suggest that the constitutive activation of NF-kB is one of the reasons contributing to the loss of MHC-dependent T cell development in the mutant mice.
Impaired Pre-TCR Downmodulation and Constitutive Pre-TCR Signaling in Cbl
2/2
, Cblb 2/2 DP Thymocytes It is generally believed that the TCR and the pre-TCR deliver signals through the same CD3 complexes; however, unlike the TCR, the pre-TCR is constitutively active even in the absence of MHC engagement (Panigada et al., 2002; Yamasaki et al., 2006) . Cbl proteins may attenuate TCR signaling through promotion of TCR downmodulation, so we speculated that the spontaneous activation of the CD4 + and CD8 + T cell development programs in Cbl 2/2 , Cblb 2/2 thymocytes might be triggered by enhanced pre-TCR signaling, resulting from impaired pre-TCR downmodulation. We found that indeed pre-TCR expression was much higher on Cbl 2/2 , Cblb 2/2 DN and DP thymocytes than on wild-type controls; however, the expression of pre-TCR was only minimally increased on the mutant CD4 + thymocytes but not detectable on the mutant CD8 + thymocytes nor on the peripheral CD4 + and CD8 + T cells ( Figure 6A and data not shown). To determine whether pre-TCR signaling is constitutively enhanced in Cbl 2/2 , Cblb 2/2 DP thymocytes, we examined pre-TCR downstream signaling including Lck activation and tyrosine phosphorylation of CD3z chain in Cbl 2/2 , Cblb 2/2 DP thymocytes. We found that even in the absence of TCR stimulation, the mutant total thymocytes as well as purified DP T cells possessed significantly higher levels of Lck (Y394) phosphorylation, which represents the active form of Lck, and of tyrosine phosphorylated CD3z chain (p21) than did the wild-type controls ( Figure 6B ). These data indicate that pre-TCR signaling is indeed enhanced in Cbl 2/2 , Cblb 2/2 DP thymocytes and support our hypothesis that the enhanced pre-TCR signaling is at least one of the reasons responsible for constitutive NF-kB activation and MHC-independent development of CD4 + and CD8 + T cells.
Discussion
MHC-dependent recognition is established during T cell development in thymus in which only those T cells expressing a TCR that recognizes either MHC-I or MHC-
II are permitted to develop further into CD4 + or CD8 + T cells (Fink and Bevan, 1978; Fowlkes and Pardoll, 1989; von Boehmer, 1988) . Our study reveals that Cbl proteins play a critical role in T cell development at multiple stages, particularly in controlling the program responsible for MHC-dependent CD4 + and CD8 + T cell genesis. In the absence of c-Cbl and Cbl-b, both CD4 + -and CD8 + -lineage T cells are efficiently generated in thymi even in the absence of MHC-I and II, indicating that Cbl proteins function as a barrier to prevent ''unauthorized'' (MHC-independent) CD4 + and CD8 + T cell development under physiological conditions. Interestingly, Cbl 2/2 , Cblb 2/2 CD4 + and CD8 + T cells generated in Cbl-MHC quadruple-deficient mice do not accumulate in the peripheral lymphoid organs. Since the survival of peripheral T cells depends on TCR-MHC interaction (Kirberg et al., 1997; Takeda et al., 1996; Tanchot et al., 1997; Viret et al., 1999; Witherden et al., 2000) , our observation may suggest that the survival signals in Cbl 
CD4
+ and CD8 + T cells cannot exit the thymus in the absence of the MHC. It has been shown that thymocyte egress from thymi depends on sphingosine-1 phosphate (S1P) signaling that is upregulated in newly generated mature thymocytes (Matloubian et al., 2004) . In this (Germain, 2002) . Our finding that Cbl 2/2 , Cblb 2/2 CD4 + and CD8 + T cells may develop in the absence of the MHC thus suggests that TCR signaling is constitutively active in Cbl 2/2 , Cblb 2/2 thymocytes. Although our experiments show that the majority of TCR-proximal signaling pathways are not spontaneously activated in Cbl 2/2 , Cblb 2/2 thymocytes, we indeed find that NF-kB but not AP-1 transcription factors are constitutively hyperactive in the mutant cells even in the absence of TCR stimulation. NF-kB controls cell development, death, and survival (Ghosh and Karin, 2002) . Under physiological conditions, however, constitutive NF-kB activity is restricted to DN3 and DN4 populations and is likely to be induced by pre-TCR signaling (Aifantis et al., 2001; Voll et al., 2000) . It has been reported that enforced expression in thymocytes of a ''superinhibitor'' of NF-kB, which inhibits endogenous NF-kB activation by 3-to 4-fold, suppresses DN4 thymocyte development. In contrast, expression of a constitutively active form of IkB kinase b in Rag2 2/2 thymocytes, which results in a 2-to 3-fold increase in NF-kB activity, promotes Rag2 2/2 thymocyte differentiation into DP T cells (Voll et al., 2000) . Interestingly, in thymi of the IkB kinase b transgenic mice, a small number of Rag2 2/2 CD4 + and CD8 + thymocytes emerge and there are more CD8 + T cells than CD4 + cells, thus suggesting that the hyperactivation of NF-kB alone may be sufficient to substitute TCR signaling, leading to a biased ratio and MHC-independent development of CD4 + and CD8 + cells (Voll et al., 2000) . Finally, it should be mentioned that in addition to the TCR, development of CD4 + -and CD8 + -lineage T cells is also regulated by Notch. At the present time, we cannot exclude the possibility that Notch signaling is altered in Cbl 2/2 , Cblb 2/2 thymocytes. Notch 1 has been shown to be ubiquitinated by c-Cbl in myoblasts in an overexpression experiment (Jehn et al., 2002) . Therefore, it will be interesting to examine whether Notch ubiquitination and expression is affected in thymocytes in the absence of Cbl proteins.
How can c-Cbl and Cbl-b selectively regulate NF-kB but not AP-1 activation in developing thymocytes? At present, it is not well understood how TCR signaling activates NF-kB in thymocytes. Because Cbl proteins function as E3 ubiquitin ligases, they may control NF-kB activation by selectively promoting ubiquitination and degradation of signaling components that act between the TCR and NF-kB, but not AP-1. Bcl-10, Carma-1, PKCq, and MALT-1 are candidate components that meet this criterion (Li and Verma, 2002; Ruland et al., 2001; Thome and Tschopp, 2003; Wang et al., 2004) . Therefore, it is worthwhile to examine whether ubiquitination and degradation of these proteins are altered in Cbl 2/2 , Cblb 2/2 thymocytes. Alternatively, we favor an idea that constitutive NF-kB activation in Cbl 2/2 , Cblb 2/2 thymocytes results from impaired pre-TCR downmodulation and degradation, since the pre-TCR signals constitutively through the CD3 complex in the absence of ligand stimulation (Aifantis et al., 2001) . It has been shown that pre-TCR downmodulation and degradation depend on c-Cbl (Panigada et al., 2002) . We found that pre-TCR expression was markedly upregulated on Cbl 2/2 , Cblb 2/2 DN and DP thymocytes that correlated with constitutive Lck activation and CD3z chain phosphorylation in the mutant DP cells ( Figure S5 ), thus indicating that the pre-TCR signaling is enhanced in these cells. However, since pre-TCR signaling activates multiple TCR signaling pathways in addition to NF-kB, other mechanisms must be involved in order to explain how the Cbl double deficiency selectively affects activation of NF-kB, but not that of AP-1. One possible explanation is that the Cbl double deficiency might also elicit other signaling pathways that selectively suppress pre-TCR-induced branch signaling leading to AP-1, but not NF-kB activation. One candidate molecule along this line is CD148, a transmembrane phosphatase that may selectively dephosphorylate LAT and PLC-g in Jurkat T cells (Baker et al., 2001 ). This possibility is supported by our preliminary data showing that CD148 is markedly upregulated on Cbl 2/2 , Cblb 2/2 DP thymocytes ( Figure S4 ). Additionally, it is also consistent with our observation that despite an enhanced tyrosine phopshorylation of CD3z chain, tyrosine phosphorylation of PLC-g and p36-38 (possibly LAT) appears to be attenuated in Cbl 2/2 , Cblb 2/2 thymocytes. Taken together, current data from our laboratory and others are consistent with our hypothesis that Cbl proteins switch MHC-independent pre-TCR signaling to MHCdependent TCR signaling in DP thymocytes, and failure to do so may result in constitutive activation of pre-TCR signaling pathways, such as NF-kB, consequently promoting T cell differentiation into CD4 + and CD8 + T cells in the absence of the MHC. Further genetic studies, with mice in which pre-TCR signaling is either attenuated or ablated in DP T cells, may help to determine whether the impaired pre-TCR downmodulation is the sole contributor to constitutive NF-kB activation and whether this is sufficient to drive the MHC-independent development of CD4 + and CD8 + T cells. Stimulation through the TCR activates a series of coordinated intracellular signaling events that control the CD4 + and CD8 + lineage-development program. However, it is worthwhile to notice that these individual signaling events can also be activated by receptors other than the TCR (Dikic and Blaukat, 1999; Ghosh and Karin, 2002; Jorissen et al., 2003 ; Sanchez-Martin et al., 2004; Zell et al., 1999) . In particular, the pre-TCR, which also signals through the CD3 complex, activates a signaling cascade similar to that activated by the TCR (Aifantis et al., 2001) . In this regard, it is conceivable that activation of these signals by receptors other than the TCR in the thymic environment may generate basal level signaling in the TCR signaling cascade and that loss of control over these ''tonic'' signals may result in accumulation of the transcription activities required for T cell development. Thus, by eradicating this ''tonic'' signaling, Cbl proteins may enforce use of the TCR to activate the CD4 + and CD8 + T cell development program under physiological conditions, thus establishing an MHCdependent mechanism for T cell development and differentiation.
One may envisage that loss of MHC dependence during T cell development might lead to the generation of T cells that recognize antigens outside of the context of MHC presentation. These cells may exist only in small numbers and may receive stimulation from native autoantigens in the periphery. The survival and activation of these cells would be dangerous for animals because they could potentially cause autoimmune diseases. In this regard, Cbl 2/2 , Cblb 2/2 mice indeed developed severe systemic autoimmune vasculitis (Naramura et al., 2002) . Given that Cbl 2/2 , Cblb 2/2 mice exhibit enhanced thymic negative seletion, which should eliminate autoreactive cells more efficiently, it will be of great interest to determine whether the development of the autoimmune disease involves non-MHC-restricted autoreactive T cells. Finally, our preliminary data suggest that Cbl 
Experimental Procedures
Mice Generation of c-Cbl floxed (Cbl f/f ) and Cblb 2/2 mice has been described previously (Chiang et al., 2000; Naramura et al., 2002) . The Lck-cre transgenic (Tg) mice were kindly provided by J. Takeda (Takahama et al., 1998 , Cblb 2/2 , Lck-cre Tg mice. The genotypes of these mice were determined by Southern blot hybridization according to a previous protocol (Naramura et al., 2002) . Cbl-MHC quadruple-deficient mice were obtained by crossing Cbl 2/2 , Cblb 2/2 mice to MHC-I and II doubledeficient mice (B2m 2/2 , Abb 2/2 ). C57BL/6 Rag2 2/2 , MHC-Ideficient (B2m 2/2 ), and MHC-I and II double-deficient mice were from Taconic (Germantown, NY). These mice were kept in specific pathogen-free facilities at the NIH and Columbia University. Animal experiments were approved by the Institutional Animal Care and Use Committees of the National Institute of Allergy and Infectious Diseases, NIH, and Columbia University.
Flow Cytometric Analysis
To study thymocyte cellularities, we collected total thymocytes from wild-type and mutant mice and prepared them as single-cell suspensions. For fluorescent staining, we stained 1 3 10 6 cells in PBS buffer containing 0.5% BSA and 0.05% azide with fluorescentcoupled antibodies on ice for 30 min. After staining, we washed cells twice with PBS buffer and analyzed the staining profiles on a FACS LSR II (BD Biosciences, San Diego, CA (Godfrey et al., 1993) . Antibodies used are the following: anti-CD4 (RM4-5), anti-CD8a (53-6.7), anti-B220 (RA3-6B2), anti-Mac-1 (M1/ 70), anti-Gr-1 (RB6-8c5), anti-NK1.1 (PK136), anti-TCRb (H57-597), anti-TCRgd (GL3), anti-CD44 (1M7), anti-CD117 (2B8), anti-CD25 (7D4), anti-HSA (M1/69), and anti-pTa (Pharmingen, San Diego, CA). The data were analyzed with FlowJo software (Tree Star, Inc., Ashland, OR).
Cell Transfer and Bone Marrow Chimera Studies
We excluded the possible influence of inflammation on the development of Cbl 2/2 , Cblb 2/2 thymocytes in mixed stem-cell bone marrow chimeras. To generate these chimeras, we intraperitoneally injected wild-type (H-2K 2 ) based on Ly9.1 expression.
Biochemical Studies
We used total thymocytes or purified DP thymocytes for biochemical analyses. DP thymocytes were purified by FACS sorting. Activation of individual signaling events in thymocytes induced by the TCR was examined according to previously published protocols (Naramura et al., 1998) . In brief, to determine tyrosine phosphorylation of total cellular proteins, we stained 1 3 10 7 total or purified DP thymocytes with biotinylated anti-CD33 (145-2C11) (5 mg/ml) alone or together with biotinylated anti-CD4 or CD8 (each 5 mg/ml) followed by straptavidin (10 mg/ml) at 37 C for 2 min. Cells were then lysed in RIPA buffer supplemented with proteinase and phosphatase inhibitors. Tyrosine phosphorylation of total proteins or activation of Erk1/2 in the lysates was determined by immunoblot with antibodies against phosphotyrosine (4G10, Upstate Biotech, Charlottesville, VA) or the anti-active forms of Erk1 and 2 (E10, New England Biolabs, Beverly, MA). To determine the tyrosine phosphorylation of Zap70, Vav, CD3z chain, and PLCg-1, we immunoprecipitated the corresponding proteins from the cell lysates and examined the levels of tyrosine phosphorylation of these proteins by western blot hybridization with 4G10 antibody. The antibodies used for immunoprecipitation were: anti-Zap70 (sc 574 AC), anti-Vav (H-21), anti-CD3z (C-20), and anti-PLCg-1 (sc-426) (Santa Cruz Biotechnologies, Inc, Santa Cruz, CA). To determine Ca 2+ mobilization, total thymocytes were loaded with Fluo-4 and Fura-red (Molecular Probes, Eugene, OR), surface stained with anti-CD4 and anti-CD8, and then stimulated with biotinylated anti-CD33 (1 mg/ml) and straptavidin (5 mg/ ml). Ca 2+ influx were determined by flow cytometry according to a previously published protocol (Naramura et al., 2002) . To determine the amount of Lck (Y394) phosphorylation, membrane was directly hybridized with rabbit anti-phosphorylated Lck (Y394) antibody (a gift from Andrey Shaw).
Thymocyte Proliferation and IL-2 Production Assay
To measure thymocyte proliferation, CFSE-labeled total thymocytes (10 5 cells/well) were stimulated in 96-well plate with plate-bound anti-CD3 (5 mg/ml) and soluble anti-CD28 (5 mg/ml) for 3 days. After the stimulation, cells were stained with anti-CD4 and anti-CD8 and then analyzed on an LSR II. For IL-2 production assay, cells were stimulated with plate-bound anti-CD3 (5 mg/ml) and soluble anti-CD28 (5 mg/ml) for 18 hr followed by incubation with 10 mg/ml Brefeldin A for 6 hr. After stimulation, cells were surface stained with anti-CD4 and anti-CD8, permeabilized, and intracellularly stained with anti-IL-2 before being subjected to FACS analysis.
Electrophoresis Mobility Gel Shift Assay
We stimulated DP thymocytes with plate-bound anti-CD33 (5 mg/ml) alone or together with soluble anti-CD28 (5 mg/ml) or PMA (10 ng/ ml) + Ionomycin (10 ng/ml) for 8-10 hr at 37 C. For unstimulated cells, we cultured DP thymocytes in the normal medium in the absence of stimuli antibodies. Nuclear extracts were prepared and EMSAs conducted according to a previous protocol (Sun et al., 2000) . To assess the binding activities of the corresponding nuclear factors, we used the following oligonucleotides: NF-kB: 5 0 -ACCAA GAGGGATTTCACCTAAATC-3 0 ; AP-1: 5 0 -CGCTTGATGACTCAGCC GGAA-3 0 . stained gel photographs are shown. These assays were performed as described previously (Hempel et al., 1998; Schlissel et al., 2000) . B) 
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